Yijin Xiao

1.0k total citations
7 papers, 826 citations indexed

About

Yijin Xiao is a scholar working on Molecular Biology, Epidemiology and Cell Biology. According to data from OpenAlex, Yijin Xiao has authored 7 papers receiving a total of 826 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Epidemiology and 2 papers in Cell Biology. Recurrent topics in Yijin Xiao's work include Sphingolipid Metabolism and Signaling (5 papers), Liver Disease Diagnosis and Treatment (2 papers) and Lipid metabolism and biosynthesis (2 papers). Yijin Xiao is often cited by papers focused on Sphingolipid Metabolism and Signaling (5 papers), Liver Disease Diagnosis and Treatment (2 papers) and Lipid metabolism and biosynthesis (2 papers). Yijin Xiao collaborates with scholars based in United States, China and Switzerland. Yijin Xiao's co-authors include Yan Xu, Saubhik Sengupta, Alexander Kennedy, Jerome L. Belinson, Yonghong Chen, Zhenwen Zhao, Rebecca Sutphen, Mitchell Hoffman, Martin A Martino and James P. LaPolla and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and The FASEB Journal.

In The Last Decade

Yijin Xiao

7 papers receiving 807 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yijin Xiao United States 6 685 147 145 128 95 7 826
Irina Baburina United States 13 430 0.6× 69 0.5× 114 0.8× 246 1.9× 24 0.3× 22 762
Douglas C. Gaudette Canada 8 563 0.8× 66 0.4× 164 1.1× 153 1.2× 21 0.2× 11 762
John L. Andrews United States 14 449 0.7× 89 0.6× 49 0.3× 40 0.3× 36 0.4× 19 730
Richard L. Boriack United States 17 536 0.8× 234 1.6× 85 0.6× 61 0.5× 27 0.3× 32 828
L. Alexis Hoeferlin United States 14 449 0.7× 88 0.6× 56 0.4× 46 0.4× 23 0.2× 21 666
André L. S. Cruz Brazil 6 389 0.6× 222 1.5× 55 0.4× 187 1.5× 32 0.3× 6 622
Elena Kolobova United States 10 561 0.8× 132 0.9× 82 0.6× 167 1.3× 24 0.3× 16 725
Cristina Di Poto United States 15 584 0.9× 187 1.3× 79 0.5× 27 0.2× 153 1.6× 32 858
Janis E. Shackelford United States 19 653 1.0× 101 0.7× 131 0.9× 92 0.7× 11 0.1× 23 796
Tatsuya Kishimoto Japan 10 659 1.0× 37 0.3× 228 1.6× 123 1.0× 17 0.2× 15 836

Countries citing papers authored by Yijin Xiao

Since Specialization
Citations

This map shows the geographic impact of Yijin Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yijin Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yijin Xiao more than expected).

Fields of papers citing papers by Yijin Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yijin Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yijin Xiao. The network helps show where Yijin Xiao may publish in the future.

Co-authorship network of co-authors of Yijin Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Yijin Xiao. A scholar is included among the top collaborators of Yijin Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yijin Xiao. Yijin Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Li, Ming, Yijin Xiao, Mark Ma, et al.. (2018). Development and validation of an LC–MS/MS Method for the quantitation of heparan sulfate in human urine. Biomedical Chromatography. 32(10). e4294–e4294. 4 indexed citations
2.
Zhao, Zhenwen, Yijin Xiao, Paul Elson, et al.. (2007). Plasma Lysophosphatidylcholine Levels: Potential Biomarkers for Colorectal Cancer. Journal of Clinical Oncology. 25(19). 2696–2701. 181 indexed citations
3.
Zhao, Xiaoxian, Dongmei Wang, Zhenwen Zhao, et al.. (2006). Caspase-3-dependent Activation of Calcium-independent Phospholipase A2 Enhances Cell Migration in Non-apoptotic Ovarian Cancer Cells. Journal of Biological Chemistry. 281(39). 29357–29368. 98 indexed citations
4.
Sutphen, Rebecca, Yan Xu, George D. Wilbanks, et al.. (2004). Lysophospholipids Are Potential Biomarkers of Ovarian Cancer. Cancer Epidemiology Biomarkers & Prevention. 13(7). 1185–1191. 294 indexed citations
5.
Sengupta, Saubhik, Yijin Xiao, & Yan Xu. (2003). A novel laminin‐induced lysophosphatidic acid autocrine loop in the migration of ovarian cancer cells. The FASEB Journal. 17(11). 1–24. 77 indexed citations
6.
Xu, Yan, Yijin Xiao, Linnea M. Baudhuin, & Benjamin Schwartz. (2001). The Role and Clinical Applications of Bioactive Lysolipids in Ovarian Cancer. Journal of the Society for Gynecologic Investigation. 8(1). 1–13. 48 indexed citations
7.
Xiao, Yijin, Yonghong Chen, Alexander Kennedy, Jerome L. Belinson, & Yan Xu. (2000). Evaluation of Plasma Lysophospholipids for Diagnostic Significance Using Electrospray Ionization Mass Spectrometry (ESI‐MS) Analyses. Annals of the New York Academy of Sciences. 905(1). 242–259. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026